Recent Advances in the Molecular Imaging of Programmed Cell Death: Part I-Pathophysiology and Radiotracers

被引:13
作者
Blankenberg, Francis G. [1 ]
Strauss, H. William [2 ]
机构
[1] Lucile Salter Packard Childrens Hosp, Dept Radiol, Div Pediat Radiol, Stanford, CA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, Nucl Med Serv, New York, NY 10021 USA
关键词
molecular imaging; oncology; apoptosis; programmed cell death; POSITRON-EMISSION-TOMOGRAPHY; MEMBRANE PHOSPHOLIPID ASYMMETRY; TUMOR GLUCOSE-UTILIZATION; TARGETED CONTRAST AGENT; ANNEXIN-V; APOPTOTIC CELLS; SYNAPTOTAGMIN-I; VIVO EVALUATION; BREAST-CANCER; C2A DOMAIN;
D O I
10.2967/jnumed.112.108944
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In humans, apoptosis (programmed cell death) is the most common form of cell death after necrosis. Apoptosis is a series of genetically preprogrammed biochemical and morphologic energy-requiring events that, after a specific external or internal stimulus, results in the physiologic disappearance of a cell via its self-disintegration and packaging of its contents into membrane vesicles called apoptotic bodies. Apoptotic bodies can readily be ingested, with their nutrients and even organelles recycled by neighboring cells or phagocytes without local inflammation. In contrast, necrosis is characterized by the primary loss of plasma membrane integrity and the uncontrolled release of a cell's contents, often causing local inflammation, tissue damage, and scarring. Alternate forms of cell death also exist, associated with specific molecular mechanisms involving enzymes, organelles, genes, external stimuli, or blockade of normal cell proliferation. In this review we will briefly outline the molecular mechanisms of apoptosis that can be imaged with radiotracers now under development.
引用
收藏
页码:1659 / 1662
页数:4
相关论文
共 57 条
[1]   Modulation of transcription by PARP-1:: Consequences in carcinogenesis and inflammation [J].
Aguilar-Quesada, R. ;
Munoz-Gamez, J. A. ;
Martin-Oliva, D. ;
Peralta-Leal, A. ;
Quiles-Perez, R. ;
Rodriguez-Vargas, J. M. ;
de Almodovar, M. Ruiz ;
Conde, C. ;
Ruiz-Extremera, A. ;
Oliver, F. J. .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (11) :1179-1187
[2]   Comparison of the C2A Domain of Synaptotagmin-I and Annexin-V As Probes for Detecting Cell Death [J].
Alam, Israt S. ;
Neves, Andre A. ;
Witney, Timothy H. ;
Boren, Joan ;
Brindle, Kevin M. .
BIOCONJUGATE CHEMISTRY, 2010, 21 (05) :884-891
[3]   Molecular imaging of cell death in vivo by a novel small molecule probe [J].
Aloya, Revital ;
Shirvan, Anat ;
Grimberg, Hagit ;
Reshef, Ayelet ;
Levin, Galit ;
Kidron, Dvora ;
Cohen, Avi ;
Ziv, Ilan .
APOPTOSIS, 2006, 11 (12) :2089-2101
[4]   On the origin, evolution, and nature of programmed cell death: a timeline of four billion years [J].
Ameisen, JC .
CELL DEATH AND DIFFERENTIATION, 2002, 9 (04) :367-393
[5]   Multimodality Molecular Imaging of Apoptosis in Oncology [J].
Blankenberg, Francis G. ;
Norfray, Joseph F. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (02) :308-317
[6]  
Boersma HH, 2005, J NUCL MED, V46, P2035
[7]   Binding of cationic liposomes to apoptotic cells [J].
Bose, S ;
Tuunainen, K ;
Parry, M ;
Medina, OP ;
Mancini, G ;
Kinnunen, PKJ .
ANALYTICAL BIOCHEMISTRY, 2004, 331 (02) :385-394
[8]   Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models [J].
Chan, A ;
Reiter, R ;
Wiese, S ;
Fertig, G ;
Gold, R .
HISTOCHEMISTRY AND CELL BIOLOGY, 1998, 110 (06) :553-558
[9]   Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography [J].
Chen, Delphine L. ;
Zhou, Dong ;
Chu, Wenhua ;
Herrbrich, Phillip E. ;
Jones, Lynne A. ;
Rothfuss, Justin M. ;
Engle, Jacquelyn T. ;
Geraci, Marco ;
Welch, Michael J. ;
Machu, Robert H. .
NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (06) :651-658
[10]   Antitumor activity and toxicological properties of doxorubicin conjugated to α,β-poly[(2-hydroxyethyl)-L-aspartamide] administered intraperitoneally in mice [J].
Cheng, Xiaoyun ;
Xue, Weihua ;
Diao, Huajia ;
Xia, Suhua ;
Zuo, Longsheng ;
He, Aijun ;
Gao, Fengbo ;
Huang, Zhen ;
Chen, Jiangning ;
Zhang, Junfeng .
ANTI-CANCER DRUGS, 2010, 21 (04) :362-371